Hospitals nationwide are seeking ways to use price transparency — displaying the price of lab tests at the time when doctors are placing the order — to nudge doctors to consider whether the benefits are worth the cost. But, results of a new study show that simply displaying the Medicare allowable fees did not have an overall impact on how clinicians ordered these tests.